thiazolyl blue has been researched along with Thyroid Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sabra, MM; Sherman, EJ; Tuttle, RM; Yeh, T; Yeung, M | 1 |
| Bufo, P; Cignarelli, M; Costantino, E; Fabiano, A; Farese, A; Landriscina, M; Maddalena, F; Piscazzi, A | 1 |
| Chung, HK; Han, HJ; Hwang, ES; Jung, NC; Kim, D; Kim, DW; Kim, H; Kim, JM; Ku, BJ; Park, KC; Ro, HK; Shong, M; Song, JH; Suh, JM; Yi, YW | 1 |
| Böckmann, M; Cranston, AN; Dahmen, U; Drosten, M; Hilken, G; Mise, N; Ponder, BA; Pützer, BM; Rödicker, F | 1 |
| Asa, SL; Ezzat, S; Liu, W; St Bernard, R; Winer, D; Zheng, L | 1 |
| Brabant, G; Jakubcakova, V; Kant, S; Kremenevskaja, N; Rao, AS; Resch, J; von Wasielewski, R | 1 |
| Delmore, JE; Hayden, P; Kotoula, V; McMillin, DW; McMullan, C; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V | 1 |
| Ishimura, H; Sasaki, F; Takada, N; Uchino, J | 1 |
| Asaga, T; Kawahara, S; Osawa, Y; Yanoma, S; Yoshida, A | 1 |
9 other study(ies) available for thiazolyl blue and Thyroid Neoplasms
| Article | Year |
|---|---|
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Prognosis; Retrospective Studies; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
Topics: Antineoplastic Agents; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Microscopy, Confocal; Neovascularization, Pathologic; Phenotype; RNA, Neoplasm; S Phase; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Thyrotropin | 2009 |
Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.
Topics: Adenoviridae; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Carcinoma; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Genes, p53; Genetic Therapy; Humans; Immunohistochemistry; Indicators and Reagents; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Protein Biosynthesis; Proteins; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
Topics: Adenoviridae; Animals; Bromodeoxyuridine; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms | 2004 |
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
Topics: Adenoviridae; Animals; Blotting, Western; Carcinoma; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, SCID; Neoplasm Transplantation; Protein-Tyrosine Kinases; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Gland; Thyroid Neoplasms; Time Factors | 2005 |
Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; beta Catenin; Blotting, Western; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Proliferation; Collagen; Drug Combinations; Fluorescent Antibody Technique; Genes, Reporter; Humans; Imatinib Mesylate; Immunoprecipitation; Laminin; Luciferases; Microscopy, Confocal; Oligonucleotide Array Sequence Analysis; Piperazines; Proteoglycans; Pyrimidines; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Thyroid Neoplasms; Transfection; Tumor Cells, Cultured | 2006 |
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma; Carcinoma, Medullary; Cell Line, Tumor; Colorimetry; Doxorubicin; Genes, bcl-2; Humans; Membrane Potentials; Oncogene Protein v-akt; Protease Inhibitors; Pyrazines; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transcription, Genetic | 2007 |
[Chemosensitivity test for thyroid cancer by in vitro MTT assay].
Topics: Antineoplastic Agents; Cisplatin; Coloring Agents; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Male; Middle Aged; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured | 1995 |
[In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Methotrexate; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured; Vincristine | 1996 |